Press Releases

77 Percent of Tilray’s Total Shares Outstanding to be Released Over Extended Two-Year Lock-up Transaction to be Non-Dilutive for Tilray and Expected to be Tax-Efficient for Privateer Stockholders   NANAIMO, British Columbia --(BUSINESS WIRE)--Sep. 9, 2019-- Tilray, Inc.

FOUR20 owns and operates six stores in Alberta and has secured 16 additional high-traffic store locations Agreement is for up to C$110M subject to the achievement of performance milestones by FOUR20 NANAIMO, British Columbia --(BUSINESS WIRE)--Aug. 29, 2019-- Tilray, Inc.

NANAIMO, British Columbia --(BUSINESS WIRE)--Aug. 22, 2019-- Tilray, Inc. (“ Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that Brendan Kennedy , President and Chief Executive Officer, and Andrew Pucher ,

Company signs $3.3 (€3) million initial supply agreement with Cannamedical Pharma GmbH to increase distribution of medical cannabis products for German patients in need Agreement represents major milestone for Tilray as EU Campus ramps up international export output through second half of 2019

Revenue Rises 371.1% to $45.9 (C$60.9) Million in the Second Quarter Compared to the Prior Year Period Canadian Adult-Use Revenue Nearly Doubles to $15.0 (C$20.0) Million Compared to Prior Quarter Key Investments Made in Europe and the U.S. as Part of Ongoing Focus on Global Expansion NANAIMO,

NYU School of Medicine will lead trials testing CBD treatment for patients with Alcohol Use Disorder and Post-Traumatic Stress Disorder with Alcohol Use Disorder NANAIMO, British Columbia --(BUSINESS WIRE)--Aug. 8, 2019-- Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research,

Additional 20 hectares of outdoor growing space increases company’s capacity to supply medical cannabis across Europe and to other international markets NANAIMO, British Columbia --(BUSINESS WIRE)--Aug. 7, 2019-- Tilray, Inc. (“ Tilray” or “the Company”) (NASDAQ:TLRY), a global pioneer in cannabis

NANAIMO, British Columbia --(BUSINESS WIRE)--Jul. 30, 2019-- Tilray Inc. (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, announced today it will report results for the second quarter ended June 30, 2019 on Tuesday, August 13, 2019 after market close.

Ireland becomes the 13 th country with Tilray medical cannabis products as company continues global expansion in Europe and increases access to patients in need NANAIMO, British Columbia --(BUSINESS WIRE)--Jul. 11, 2019-- Tilray Inc. (TLRY:NASDAQ), a global pioneer in cannabis cultivation,

Top talent from European pharmaceutical and beverage industries join Tilray’s leadership team as company accelerates growth in international markets NANAIMO, British Columbia --(BUSINESS WIRE)--Jul. 5, 2019-- Today, Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production, research,